Tailor Made Compounding
This is one entry from the TitrateLab Vendor Graveyard, a dated, primary-source archive of peptide-market shutdowns, exit scams, and enforcement actions. Documented as October 30, 2020. Sources for this entry are named inline below and numbered in full on the parent archive page.
The case that set the template for every peptide-compounder conviction since.
Tailor Made Compounding LLC (Nicholasville, Kentucky) and its founder Jeremy Delk pleaded guilty to distributing unapproved new drugs from October 2018 through April 2020. The plea covered BPC-157, CJC-1295, Ipamorelin, Melanotan II, MK-677, LGD-4033, Selank, Semax, DSIP, Epitalon, and other peptides and SARMs. The pharmacy forfeited $1,788,906.82 (DOJ EDKY release), essentially its 2019 sales of those products. Delk received 3 years probation (including 4 months home incarceration), 100 hours community service, a $20,000 fine, and a lifetime ban from prescription-drug distribution.
Why it still matters: first high-profile criminal conviction of a licensed 503A compounding pharmacy for peptide distribution. Confirmed that the 503A bulks list isn’t an administrative line — it’s an enforceable criminal one. Every subsequent FDA enforcement action traces back to this case.
Primary sources: FDA OCI press release; DOJ EDKY sentencing release.